Critical Outcome Investor Presentation - March 2014
Critical Outcome - Investor Update - July 2013
Critical Outcome Technologies - Investor Presentation - June 2013
Pathway to the clinic and beyond
A promising advance for many cancers
Critical Outcome - Investor Presentation - January 2014
COTI-2 | Reactivating Mutant p53
Introducing ROSALIND
Critical Outcome Technologies Business & Scientific Updates
Critical Outcome BIO Investor Forum
Critical Outcome - September 2014
Critical Outcome Technologies at the BIO Investor Forum 2014
More than just a potential BREAKTHROUGH treatment for many cancers
Small-Cap Stars
COTI Overview
Business and Scientific Update
2016 Annual General & Special Meeting of Shareholders
Critical Outcome investor presentation - November 2015
COTI Corporate Presentation at Cantech 2017
